Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Tan

Showing results (981-990 of 1,101) with videos related to

Pageof 111
Sort By:
Human Genomics|July 17, 2023
Landscape of germline pathogenic variants in patients with dual primary breast and lung cancerNing-Yuan Lee, Melissa Hum, Sabna Zihara, et al.
JTO Clinical and Research Reports|June 6, 2022
Long-Term Efficacy and Safety of Entrectinib in <i>ROS1</i> Fusion-Positive NSCLCAlexander Drilon, Chao-Hua Chiu, Yun Fan, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 6, 2021
Clinical definition of acquired resistance to immunotherapy in patients with metastatic non-small-cell lung cancerA J Schoenfeld, S J Antonia, M M Awad, et al.
Zhonghua Liu Xing Bing Xue Za Zhi = Zhonghua Liuxingbingxue Zazhi|July 31, 2018
[Alcohol consumption and the risk of lung cancer in males: a prospective cohort study]L P Wei, N Li, G Wang, et al.
Zhonghua Yu Fang Yi Xue Za Zhi [Chinese Journal of Preventive Medicine]|May 11, 2018
[Tea consumption and the risk of lung cancer in Chinese males: a prospective cohort study]X Li, N Li, G Wang, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 20, 2011
Gefitinib, cisplatin, and concurrent radiotherapy for locally advanced head and neck cancer: EGFR FISH, protein expression, and mutational status are not predictive biomarkersE-H Tan, C Goh, W T Lim, et al.
The Lancet. Digital Health|December 17, 2020
Artificial intelligence for teleophthalmology-based diabetic retinopathy screening in a national programme: an economic analysis modelling studyYuchen Xie, Quang D Nguyen, Haslina Hamzah, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|May 13, 2026
Clinical and Genetic Characterization of Constitutional MLH1 Promoter Hypermethylation: Implications for Lynch Syndrome DiagnosisMegan F H Bishop, Nisha Kanwar, Lauren E Schefter, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 30, 2023
Lung Cancer Screening in Asia: An Expert Consensus ReportDavid Chi-Leung Lam, Chong-Kin Liam, Sita Andarini, et al.
The Lancet Regional Health. Western Pacific|January 6, 2025
Consensus on the lung cancer management after third-generation EGFR-TKI resistanceQing Zhou, Hongyun Zhao, Shun Lu, et al.
Pageof 111

Showing results (981-990 of 1,101) with videos related to

Sort By:
Pageof 111
Human Genomics|July 17, 2023
Landscape of germline pathogenic variants in patients with dual primary breast and lung cancerNing-Yuan Lee, Melissa Hum, Sabna Zihara, et al.
JTO Clinical and Research Reports|June 6, 2022
Long-Term Efficacy and Safety of Entrectinib in <i>ROS1</i> Fusion-Positive NSCLCAlexander Drilon, Chao-Hua Chiu, Yun Fan, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 6, 2021
Clinical definition of acquired resistance to immunotherapy in patients with metastatic non-small-cell lung cancerA J Schoenfeld, S J Antonia, M M Awad, et al.
Zhonghua Liu Xing Bing Xue Za Zhi = Zhonghua Liuxingbingxue Zazhi|July 31, 2018
[Alcohol consumption and the risk of lung cancer in males: a prospective cohort study]L P Wei, N Li, G Wang, et al.
Zhonghua Yu Fang Yi Xue Za Zhi [Chinese Journal of Preventive Medicine]|May 11, 2018
[Tea consumption and the risk of lung cancer in Chinese males: a prospective cohort study]X Li, N Li, G Wang, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 20, 2011
Gefitinib, cisplatin, and concurrent radiotherapy for locally advanced head and neck cancer: EGFR FISH, protein expression, and mutational status are not predictive biomarkersE-H Tan, C Goh, W T Lim, et al.
The Lancet. Digital Health|December 17, 2020
Artificial intelligence for teleophthalmology-based diabetic retinopathy screening in a national programme: an economic analysis modelling studyYuchen Xie, Quang D Nguyen, Haslina Hamzah, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|May 13, 2026
Clinical and Genetic Characterization of Constitutional MLH1 Promoter Hypermethylation: Implications for Lynch Syndrome DiagnosisMegan F H Bishop, Nisha Kanwar, Lauren E Schefter, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 30, 2023
Lung Cancer Screening in Asia: An Expert Consensus ReportDavid Chi-Leung Lam, Chong-Kin Liam, Sita Andarini, et al.
The Lancet Regional Health. Western Pacific|January 6, 2025
Consensus on the lung cancer management after third-generation EGFR-TKI resistanceQing Zhou, Hongyun Zhao, Shun Lu, et al.
Pageof 111